A Community Health Worker (CHW) is a frontline public health worker who is a trusted member of the community they serve. CHWs act as a bridge between health and social services and the community, helping to improve health outcomes and access to care.

Our goal during this episode is to discuss why training pharmacy technicians to step into the role of a Community Health Worker has been imperative to meeting the health equity demands in local communities.

Host
Jen Moulton, BSPharm
President
CEimpact

Guest
Meredith Ayers, CPhT-Adv, CHW
Development Specialist
Bremo Pharmacy

Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Evaluate the role and impact of pharmacy-placed Community Health Workers (CHWs) on patient outcomes and community health.
2. Describe a plan to integrate CHWs into pharmacy practice by cross-training pharmacy technicians.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-260-H04-P
Initial release date: 9/9/2024
Expiration date: 9/9/2025
Additional CPE details can be found here.

Drug resistance to antibiotics continues to escalate. This week we do a deep dive into the Infectious Disease Society of America's (IDSA) brand new guidance on the treatment of antimicrobial resistant gram-negative infections.
 
The GameChanger
The new IDSA guidelines provide critical, evidence-based recommendations for managing drug-resistant gram-negative infections. The guidance offers health care providers clear strategies to improve outcomes and reduce the emergence of resistance.

Host
Jen Moulton, BSPharm
President, CEimpact

Guests
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Amanda Bushman, PharmD,BCPS-AQ ID, BCIDP, FIDSA
Infectious Disease Pharmacist
UnityPoint Health

Tony Mannum, PharmD
PGY2 Infectious Disease Resident
UnityPoint Health

Reference
IDSA Guidelines for treating resistant gram negative organisms

Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify effective strategies for treating urinary tract and systemic infections caused by Extended-Spectrum Beta-Lactamase (ESBL)-producing organisms.
2. Discuss appropriate therapeutic agents for infections caused by AmpC beta-lactamase-producing bacteria, ensuring choices minimize the risk of resistance development during treatment.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-251-H01-P
Initial release date: 09/02/2024
Expiration date: 09/02/2025
Additional CPE details can be found here.

Unlock the secret to a thriving pharmacy with our latest podcast episode! Discover how investing in highly trained and skilled pharmacy technicians can transform your operations. Join us as expert guest speakers share invaluable insights and explore Health Mart's innovative technician training solutions. Hear compelling firsthand stories from independent community pharmacists who have revolutionized their businesses by empowering their pharmacy technicians. Don't miss this chance to elevate your pharmacy to new heights—tune in now!

Host
Suzanne Feeney, PharmD
VP, Pharmacy Retail Operations
McKesson, Health Mart

Guests
Sandie Kueker
Owner
Hesston Pharmacy

Brittany Hoffmann-Eubanks, PharmD, MBA
ASHP/ACPE Accredited Training Program Director
McKesson, Health Mart

Patricia Motl
Pharmacy Manager
Hugo's Pharmacies

References
Health Mart franchise members can learn more about Health Mart’s technician training solutions here (https://my.healthmart.com/technicianTrainingHome.htm)

To learn more about ASHP/ACPE Accredited Technician Training Standards visit ASHP’s website at: https://www.ashp.org/professional-development/technician-program-accreditation


The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

The Society of Critical Care Medicine just released their first set of updated stress ulcer prophylaxis (SUP) guidelines since 1999 that include groundbreaking changes. We also discuss evidence on proton pump inhibitor (PPI) use for SUP that impacts ICU practice.
 
The GameChanger
New guidelines for use of PPIs for stress ulcer prophylaxis will have a significant impact on ICU practice.

Host
Jen Moulton, BSPharm
President, CEimpact

Guest
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Matthew Trump, DO, FACP, FCCP
Pulmonologist
The Iowa Clinic

Reference
Guidelines
Paper

Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the new Stress Ulcer Prophylaxis (SUP) guidelines from the Society of Critical Care Medicine (SCCM), including identifying patients at risk.
2. Discuss the use of Proton Pump Inhibitors (PPI) and Histamine-2 Receptor Antagonists (H2RA) for Stress Ulcer Prophylaxis (SUP).

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-247-H01-P
Initial release date: 08/26/2024
Expiration date: 08/26/2025
Additional CPE details can be found here.

Dementia is the 6th leading cause of death in the U.S. and there hasn't been a lot of hope with prevention or treatment. However, recently published evidence suggests the shingles vaccine may delay its onset.
 
The GameChanger
Several studies suggest a delay in onset of dementia with the recombinant shingles vaccine.

Host
Jen Moulton, BSPharm
President, CEimpact

Guest
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Reference
The recombinant shingles vaccine is associated with lower risk of dementia

Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe dementia's epidemiology and the significance of preventive interventions.
2. Discuss the strengths, weaknesses, and outcomes of the study.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-246-H01-P
Initial release date: 08/19/2024
Expiration date: 08/19/2025
Additional CPE details can be found here.

We delve into the implications of the recent study published in JAMA Internal Medicine, exposing how older risk models overestimate cardiovascular risk by about 50%. This overestimation has profound implications for primary statin use, insurer policies, and regulatory practices. Our discussion highlights the need for updated guidelines that reflect the most current evidence, ensuring better patient care and aligning clinical practice with the latest scientific findings.
 
The GameChanger
Adopting the PREVENT equations could significantly refine statin prescriptions, ensuring millions of adults receive appropriate cardiovascular risk management.
 
Host
Jen Moulton, BSPharm
President, CEimpact

Guests
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad

Reference
Atherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events Equations

Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the impact of the PREVENT equations on statin prescription recommendations for cardiovascular disease prevention.
2. Explain clinical implications and practice changes from integrating the PREVENT equations into cardiovascular risk guidelines.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-245-H01-P
Initial release date: 08/12/2024
Expiration date: 08/12/2025
Additional CPE details can be found here.

The power of physical fitness in managing diabetes is transforming patient care. Join us this week as we discuss how pharmacists can significantly enhance patient outcomes by integrating exercise education into their practice, alongside traditional medication management.
 
The GameChanger
Incorporating brief but impactful conversations about the importance of physical fitness into patient consultations can significantly enhance diabetes management.
 
Host
Jen Moulton, BSPharm
President, CEimpact

Guests
Mark Smith, Jr., PharmD, CDCES, AFAA-CGFI
Pharmacist
UAB Medicine

Ian Haywood, PharmD, BCPS, CDCES
Clinical Pharmacist
Baptist Memorial Hospital

 
Reference
The Role of Exercise in Diabetes
Physical Activity and Diabetes Position from the ADA

Supplemental Continuing Education Courses on HMU
Glucose Whisperers: The Role of CGMs in Pharmacy Practice - 1hr
Guardians of the Glucose Galaxy: The Rise of CGMs - 1hr
Pharmacy and Continuous Glucose Monitoring: The Sweetest Pairing - 6.5hrs

Additional GameChangers Episodes
Continuous Glucose Monitors

Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the impact of physical fitness on diabetes management.
2. Identify strategies for educating patients on exercise and diabetes.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-224-H01-P
Initial release date: 08/05/2024
Expiration date: 08/05/2025
Additional CPE details can be found here.

GLP1 usage is on the rise. This week on GameChangers, we discuss the latest data on using GLP-1s for sleep apnea and weight loss.
 
The GameChanger
Several new studies suggest GLP-1 and GLP/GIP medications have positive clinical impact on sleep apnea and weight loss.

Host
Jen Moulton, BSPharm
President, CEimpact

Guests
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad

Reference
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity

Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the use of GLP-1 medications in the treatment of obstructive sleep apnea.
2. Discuss the relative weight loss in a recent study between a GLP-1 and GLP/GIP drugs.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-238-H01-P
Initial release date: 07/29/2024
Expiration date: 07/29/2025
Additional CPE details can be found here.

The US is currently in the DSCSA stabilization period through November 27, 2024. Learn about the latest DSCSA details, including the most recent announcement from the FDA on exemptions from a leading DSCSA expert.

Host
Suzanne Feeney, PharmD
VP, Pharmacy Retail Operations
McKesson, Health Mart

Guests
Scott Mooney
VP, Distribution Operations
McKesson

References
Access the FDA Drug Supply Chain Security Act (DSCSA) website (https://www.fda.gov/drugs/drug-supply-chain-integrity/drug-supply-chain-security-act-dscsa) to learn more about DSCSA.

Access the July 12, 2024 FDA Notification (https://www.fda.gov/media/179256/download?attachment) on DSCSA Exemptions from Certain Requirements Under Section 582 of the FD&C Act for Small Business Dispensers (revised with clarifying edits to June 12, 2024, letter).

Learn more about how pharmacies should prepare as the DSCSA stabilization Period Ends in this article (https://www.drugtopics.com/view/how-pharmacies-should-prepare-as-the-dscsa-stabilization-period-ends).


The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

1 out of 3 adult Americans take a daily multivitamin. On this episode of GameChangers, we discuss a recent study which examined whether daily multivitamin use extends life or prevents common causes of death.
 
The GameChanger
The study found no evidence that daily multivitamin use reduced death from common conditions such as heart disease or cancer.
 
Host
Jen Moulton, BSPharm
President, CEimpact

Guest
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO, Seguridad

References
Multi-Vitamin Study
NIH Press Release

Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the use of multivitamins.
2. Identify implications for healthy patients considering multivitamin use.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-226-H01-P
Initial release date: 07/22/2024
Expiration date: 07/22/2025
Additional CPE details can be found here.